Lipohexin, a new inhibitor of prolyl endopeptidase from Moeszia lindtneri (HKI-0054) and Paecilomyces sp. (HKI-0055; HKI-0096). I. Screening, isolation and structure elucidation

  • J Antibiot (Tokyo). 1997 May;50(5):379-83. doi: 10.7164/antibiotics.50.379.
S Heinze  1 ,  M Ritzau ,  W Ihn ,  H Hülsmann ,  B Schlegel ,  K Dornberger ,  W F Fleck ,  M Zerlin ,  C Christner ,  U Gräfe ,  G Küllertz ,  G Fischer
Affiliations
  • 1. Hans-Knöll-Institute of Natural Products Research, Jena, Germany.
PMID: 9207906 DOI: 10.7164/antibiotics.50.379
Abstract

Lipohexin was isolated as a novel lipohexapeptide (I) (C39H68N6O9) from three Fungal strains, Moeszia lindtneri HKI-0054, Paecilomyces sp. HKI-0055 and Paecilomyces sp. HKI-0096. The structure was elucidated by detailed mass spectrometric and NMR experiments. The proline-containing peptide displays moderate Antibacterial activity against Bacillus subtilis ATCC 6633 and inhibits competitively the prolyl endopeptidase from human placenta.

Products